Please use this identifier to cite or link to this item:
|Title:||The need for a marker predicting benefit following cardiovascular disease risk reduction treatment|
|Citation:||Ticagrelor Science Conference, Vienna, Austria, 15th-16th June 2015|
|Abstract:||Developing a robust method to study characteristics of vascular flow using ultrasound may be useful to assess endothelial function and vasodilatation. There are four stages in this proposal. 1.The first stage is to standardise and validate the methodology to enable computational risk flow data and other flow characteristics to be used clinically. (Current Study). Further development of fluid modelling methods will enable particulate haemodynamics to be investigated, and incorporate detailed endothelial structure together with cellular pathways. 2. This should be followed up by studies in different patient groups investigating the association between the derived values and estimated risk (using other methods such as Framingham risk score). 3. Then, associated with underlying cardiovascular risk, prospective studies would be made to establish whether computational flow dynamic data can predict outcome. If successful it could prove to be a very useful marker of benefit following treatment in a clinical setting.|
|Appears in Collections:||Dept of Mechanical Aerospace and Civil Engineering Research Papers|
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.